Dedicated solely to the laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis for the past 50 years
The Toxoplasma Serology Laboratory, a not-for-profit institution, has been dedicated solely to the laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis for the past 50 years. Our diagnostic efforts are focused on the pregnant woman, fetus and newborn, as well as the patient who has an impaired immune system or eye disease. Instrumental to our mission is the development of tests to improve and expand diagnostic capabilities in the field of toxoplasmosis. The majority of tests we perform were developed in our laboratory, and are not performed by other laboratories in this country.
Forms
For use by medical and laboratory professionals only.
- Testing in Pregnant Women
- Testing in Newborns and Infants (1 year of age or younger)
- Testing in Non-Pregnant Adults and Older Children (more than 1 year of age)
- Immunocompromised Patient
- Specimen Requirements and Testing Information
All forms are Acrobat PDF files - download the free Acrobat Reader (opens to new window) if needed.
What's New
Management of Toxoplasma gondii Infection during Pregnancy, Jose G. Montoya and Jack S. Remington, Clinical Infectious Diseases 2008; 47:554–66, Published with permission
Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment
Important Updates
Please Read: What's New For 2013
Toxoplasma Serology Lab Survey -- We would like to hear your feedback about our services.
Additional Information
We serve as the reference laboratory for the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA), and have worked with these agencies to disseminate information to the medical professions and public about toxoplasmosis and its diagnosis.
Physicians in the Toxoplasma Serology Laboratory also offer interpretation of our test results and consultation on treatment and patient management to clinicians in the United States and worldwide. Our confirmatory battery of tests on sera of pregnant women with positive IgM antibodies reported by other laboratories has been shown to decrease unnecessary abortions by 50 percent.